GLPcompareGLPcompare
DrugsPricesCompareShortagesEvidenceSupplementsWatchlist
Live feed

GLP-1 news and safety alerts

FDA approvals, safety alerts, and recalls for GLP-1 drugs. Each links to the original.

Last checked · Sep 23, 2026 UTC

The latest GLP-1 safety and news items from the FDA: press announcements, MedWatch alerts, and drug recalls. 30 items indexed, newest first.

Aug 19, 2026

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

  • RecallApollo Care, LLCClass II6 wk ago

    Recall: SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial

    Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

May 27, 2026

  • RecallLupin Pharmaceuticals Inc.Class II4 mo ago

    Recall: Liraglutide Injection, 18 mg/3 mL (6 mg/mL)

    Presence of particulate matter: a white thread-like structure in the cartridge

Apr 22, 2026

  • RecallPAYLESS COMPOUNDERS, LLCClass II5 mo ago

    Recall: Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials

    Lack of Assurance of Sterility

Mar 11, 2026

  • RecallNew Life Pharma LLCClass II7 mo ago

    Recall: Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial

    Lack of Assurance of Sterility

  • RecallHarbin Jixianglong Biotech Co., Ltd.Class II7 mo ago

    Recall: Semaglutide, For Rx compounding use only, packaged in

Jan 7, 2026

  • RecallNovo Nordisk Inc.Class II9 mo ago

    Recall: Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens

    Presence of Particulate Matter: Hair was found in a prefilled syringe

  • RecallNovo Nordisk Inc.Class II9 mo ago

    Recall: Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens

Nov 5, 2025

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use

Oct 15, 2025

  • RecallGenoGenix LLCClass II12 mo ago

    Recall: Semaglutide for Injection

    Lack of Assurance of Sterility

  • RecallGenoGenix LLCClass II12 mo ago

    Recall: Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations,…

Sources: FDA Press Announcements (RSS) , FDA MedWatch Safety Alerts (RSS), and openFDA Drug Enforcement (Recalls). This feed is filtered to items relevant to GLP-1 medications; it is informational only, not medical advice. Read the full FDA record for the complete, authoritative statement.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

  • RecallNew Life Pharma LLCClass II7 mo ago

    Recall: Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial

    Lack of Assurance of Sterility

  • RecallNew Life Pharma LLCClass II7 mo ago

    Recall: Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial

    Lack of Assurance of Sterility

  • RecallNew Life Pharma LLCClass II7 mo ago

    Recall: Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial

    Lack of Assurance of Sterility

  • RecallHarbin Jixianglong Biotech Co., Ltd.Class II7 mo ago

    Recall: Semaglutide, For Rx compounding use only, packaged in

    CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

    • Presence of Particulate Matter: Hair was found in a prefilled syringe

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

  • RecallProRx LLCClass II11 mo ago

    Recall: Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use

    Lack of Assurance of Sterility

    • Lack of Assurance of Sterility